Predictive Oncology Inc. (POAI) files for 5.97M share offering by selling stockholders Nov 20, 2025 05:04PM
Predictive Oncology partners with Every Cure for drug repurposing Sep 4, 2025 09:03AM
Predictive Oncology secures $10 million funding for ChemoFx expansion Jul 15, 2025 09:01AM
Predictive Oncology secures $10M equity purchase agreement with Yorkville Jul 8, 2025 09:02AM
Predictive Oncology (POAI) Develops Functional 3D Organoid Models Exclusively for Labcorp Jun 12, 2025 08:31AM


May 27, 2025 08:35AM Court Denies Renovaro Motion for an Expedited Trial in July
May 22, 2025 08:16AM Predictive Oncology Inc. (POAI) Says Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
May 15, 2025 04:40PM Predictive Oncology Inc. (POAI) Misses Q1 EPS by 32c
Apr 4, 2025 09:41AM Renovaro Biosciences (RENB) Provides Update to Definitive Agreement with Predictive Oncology (POAI)
Feb 19, 2025 08:03AM Predictive Oncology (POAI) Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Feb 10, 2025 08:00AM Predictive Oncology (POAI) Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
Jan 16, 2025 08:00AM Predictive Oncology Inc. (POAI) Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
Jan 6, 2025 02:46PM SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Predictive Oncology Inc. Buyout
Jan 6, 2025 09:10AM Predictive Oncology (POAI) to be Acquired by Renovaro
Jan 6, 2025 09:05AM Predictive Oncology Inc. (POAI) Halted, News Pending
Dec 3, 2024 07:02AM Predictive Oncology (POAI): Comprehensive due diligence remains ongoing with several parties
Nov 13, 2024 04:15PM Predictive Oncology Inc. (POAI) Misses Q3 EPS by 36c
Aug 27, 2024 08:11AM Predictive Oncology (POAI) Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
Aug 19, 2024 06:08AM H.C. Wainwright Starts Predictive Oncology (POAI) at Buy
Aug 15, 2024 05:19PM Predictive Oncology Inc. (POAI) Files for 1.98M Share Offering by Selling Stockholders
Aug 14, 2024 07:19AM Predictive Oncology Inc. (POAI) Misses Q2 EPS by 68c
Aug 13, 2024 07:01AM Predictive Oncology (POAI) Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
Jul 26, 2024 08:03AM Predictive Oncology (POAI) Announces Exercise of Warrants for $1.26 Million Gross Proceeds
Jul 25, 2024 07:08AM Predictive Oncology (POAI) Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
Jun 11, 2024 08:04AM Predictive Oncology (POAI) Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors